
Canara Robeco files draft papers with Sebi for IPO. Issue to be OFS
Canara Robeco
Asset Management Company has filed draft papers with market regulator Securities and Exchange Board of India (Sebi) for an initial public offering (
IPO
) which will be an offer for sale (
OFS
).
Canara Bank
and ORIX Corporation Europe N.V, which are promoters of the company will collectively offer up to 49,854,357 equity shares, In this, Canara Bank will offer up to 25,924,266
equity Shares
while ORIX will sell up to 23,930,091 equity shares, the Draft Red Herring Prospectus (DRHP) said.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
เทรดทองCFDs กับโบรกเกอร์ที่เชื่อถือได้ | เรียนรู้เพิ่มเติม
IC Markets
สมัคร
Undo
Canara Robeco Asset Management Company's primary activities include managing
mutual funds
and providing investment advice on Indian equities. As of December 31, 2024, the company managed 25 schemes comprising 12 equity schemes, 10 debt schemes and three hybrid schemes with a quarterly average assets under management (AUM) of Rs 1,08,366 crore.
The company has a multi-channel sales and distribution network that allows it to offer products and services to its customers. This network includes third-party distributors, and sales made through its branches, and digital platforms.
Canara Robeco AMC has witnessed a growth in its QAAUM, growing at a CAGR of 34.75% between March 31, 2022, to March 31, 2024, compared to industry growth of 18.8%, the DRHP said citing a CRISIL report. The same report adds that the company had the third highest share of equity (including equity-oriented hybrid) AUM as of and compared to the top 10 AMCs in India, had the highest share of equity-oriented AUM as of December 31, 2024.
Live Events
The equity shares are proposed to be listed on the BSE and NSE.
SBI Capital Markets Limited,
Axis Capital Limited
and
JM Financial Limited
are the Book Running Lead Managers to the issue. MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) will be the registrar for the public issue.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
5 minutes ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.


Time of India
15 minutes ago
- Time of India
Maharashtra IT department emerges as primary cloud service provider for govt departments
Pune: Maharashtra's Information Technology Corporation Ltd (MahaIT) has become the main cloud service provider for govt departments. Senior state IT officials confirmed that several departments have already began migrating their data to MahaIT's cloud platform, marking a strategic shift in the state's data management approach. Tired of too many ads? go ad free now "It is a win-win situation — departments gain peace of mind regarding data safety and security, while we strengthen our capabilities in cloud services," said an official. The move has come in the aftermath of a major controversy earlier this year when MahaIT filed a criminal complaint against a private cloud vendor and its directors over alleged extortion and threats to delete sensitive govt data. The FIR accused the firm of breaching contract terms and blocking access to services for eight departments after invoicing for undelivered services. The matter escalated to Bombay High Court, which directed affected departments to transfer their data to MahaIT's cloud. Launched under Maharashtra's 2018 public cloud policy — the first of its kind in India — the state mandated all govt departments to store data on cloud platforms, opening a Rs 200 crore opportunity for cloud service providers. However, concerns over security and vendor reliability have since prompted a greater push for in-house cloud solutions. Currently, MahaIT is in discussion with multiple departments to broaden cloud adoption on its platform, aiming to consolidate govt data under a single, secure service provider. Many departments, such as the state registration department, the agriculture department, and many others, have shifted to cloud. "There are several departments that are already using cloud services. We will reach out to all departments and put across our services,'' an IT official added.

Mint
16 minutes ago
- Mint
Infosys shares to be in focus after DGGI closed ₹32,403 crore pre-show cause GST notice
India's second-largest IT firm, Infosys Ltd, received a goods and services tax (GST) demand closure notice on Friday, 6 June 2025. The notice relieved the company from a ₹ 32,403 crore tax order from the Director General of GST Intelligence (DGGI). 'The company has today received a communication from the Director General of GST Intelligence (DGGI) closing the pre-show cause notice proceedings for the financial years 2018-19 to 2021-22,' according to the BSE filing. The data also showed that the DGGI earlier asked for a ₹ 32,403 crore GST demand notice for the issue of non-payment of IGST under the Reverse Charge Mechanism. 'With the receipt of today's communication from DGGI, this matter stands closed,' said Infosys in the BSE filing. Infosys shares closed 0.62 per cent higher at ₹ 1,564.05 after Friday's stock market session, compared to ₹ 1,554.35 at the previous market close. The company received the GST demand closure notice after stock market operating hours on 6 June 2025. IT major shares have given stock market investors more than 126 per cent returns on their investments in the last five years and 4.55 per cent in the last one-year period. On a year-to-date (YTD) basis, the shares have lost 16.71 per cent in 2025. However, the stock is trading 3.74 per cent higher in the last one-month period. Infosys shares hit their 52-week high level at ₹ 2,006.80 on 13 December 2024, while the 52-week low level was at ₹ 1,307.10 on 17 April 2025, according to the data collected from the BSE website. The IT major's market capitalisation (M-Cap) was at ₹ 6,49,739.73 crore as of Friday, 6 June 2025. Infosys's January to March quarter results for the financial year ended 2024-25 witnessed an 11.75 per cent year-on-year (YoY) fall to ₹ 7,033 crore, compared to ₹ 7,969 crore in the same period a year ago, according to the consoldiated financial statements. The revenue from core operations for the fourth quarter rose 8 per cent YoY to ₹ 40,925 crore from ₹ 37,923 crore in the corresponding quarter of the last financial year. Read all stories by Anubhav Mukherjee